Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats

Fig. 1

Representative echocardiographic imaging of the atria obtained during left ventricular end-systole and hemodynamic images from the four different groups. A Representative measurements echocardiographic imaging of the left atria in control group, diabetes mellitus group, low-dose empagliflozin group and high-dose empagliflozin group. a, left ventricle; b, left atria; c, ascending aorta. B Representative hemodynamic imaging for the four study groups. Each group included 8 rats

Back to article page